LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
+3.22%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.6B
AUM Growth
+$3.6B
(+29%)
Cap. Flow
+$751M
Cap. Flow
% of AUM
20.87%
Top 10 Holdings %
Top 10 Hldgs %
28.81%
Holding
467
New
156
Increased
40
Reduced
28
Closed
91
Top Buys
| 1 |
Apple
AAPL
|
$109M |
| 2 |
CVS Health
CVS
|
$96M |
| 3 |
Adobe
ADBE
|
$90.1M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$70.7M |
| 5 |
Microsoft
MSFT
|
$69.4M |
Top Sells
| 1 |
Kenvue
KVUE
|
$156M |
| 2 |
Vistra
VST
|
$144M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
$121M |
| 4 |
General Motors
GM
|
$85M |
| 5 |
Honeywell
HON
|
$72.5M |
Sector Composition
| 1 | Healthcare | 38.37% |
| 2 | Technology | 18.29% |
| 3 | Consumer Discretionary | 9.42% |
| 4 | Financials | 7.94% |
| 5 | Energy | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Biomea Fusion
BMEA
$119M
| $40.7M | 0.34% |
2,720,983
-15,384
| -0.6% | -$230K |
|
27
Lam Research
LRCX
$123B
| $39.3M | 0.33% |
+40,441
| New | +$39.3M |
|
28
Visa
V
$678B
| $37.3M | 0.32% |
+133,767
| New | +$37.3M |
|
29
Marathon Petroleum
MPC
$54.4B
| $36.5M | 0.31% |
181,383
+163,934
| +940% | +$33M |
|
30
Cytokinetics
CYTK
$5.81B
| $36.5M | 0.31% |
+519,918
| New | +$36.5M |
|
|
X
31
DELISTED
US Steel
X
| $36.3M | 0.31% |
889,057
-747,433
| -46% | -$30.5M |
|
32
NextEra Energy, Inc.
NEE
$149B
| $34.3M | 0.29% |
536,146
-347,821
| -39% | -$22.2M |
|
33
89bio
ETNB
$1.37B
| $31.4M | 0.27% |
2,699,470
-4,732
| -0.2% | -$55.1K |
|
34
Macy's
M
$4.31B
| $31.4M | 0.27% |
+1,570,724
| New | +$31.4M |
|
|
EXAI
35
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $30.9M | 0.26% |
5,409,533
| – | – |
|
36
Automatic Data Processing
ADP
$121B
| $29.8M | 0.25% |
119,472
+58,284
| +95% | +$14.6M |
|
37
Crinetics Pharmaceuticals
CRNX
$3.22B
| $29.5M | 0.25% |
630,182
+61,200
| +11% | +$2.86M |
|
38
S&P Global
SPGI
$165B
| $28.8M | 0.24% |
+67,588
| New | +$28.8M |
|
39
Vertex Pharmaceuticals
VRTX
$102B
| $28M | 0.24% |
+66,893
| New | +$28M |
|
40
Phillips 66
PSX
$52.8B
| $25.6M | 0.22% |
157,000
+148,669
| +1,785% | +$24.3M |
|
41
Pfizer
PFE
$141B
| $25M | 0.21% |
900,000
-1,545,346
| -63% | -$42.9M |
|
42
Goldman Sachs
GS
$221B
| $24.5M | 0.21% |
58,558
-104,800
| -64% | -$43.8M |
|
43
Analog Devices
ADI
$120B
| $22.8M | 0.19% |
+115,487
| New | +$22.8M |
|
44
Cadence Design Systems
CDNS
$94.4B
| $21.2M | 0.18% |
+68,000
| New | +$21.2M |
|
45
RTX Corp
RTX
$211B
| $20.1M | 0.17% |
206,063
+122,455
| +146% | +$11.9M |
|
46
T-Mobile US
TMUS
$285B
| $19.5M | 0.17% |
119,750
-42,943
| -26% | -$7.01M |
|
47
Boeing
BA
$176B
| $19M | 0.16% |
98,365
-95,847
| -49% | -$18.5M |
|
|
SWTX
48
DELISTED
SpringWorks Therapeutics
SWTX
| $18.3M | 0.16% |
372,074
| – | – |
|
49
AB InBev
BUD
$117B
| $18.1M | 0.15% |
+297,304
| New | +$18.1M |
|
50
Bausch + Lomb
BLCO
$5.24B
| $17.9M | 0.15% |
1,033,880
| – | – |
|